News

Positive Phase 3 Results for New Cholesterol Tx Presented

Regeneron and Sanofi announced new positive results for Praluent (alirocumab) from the Phase 3 ODYSSEY clinical trial program in heterozygous familial hypercholesterolemia (HeFH) patients.

Fewer Side Effects Seen With Half-Dose Diuretic Combo vs. Single Diuretic

Results from the PATHWAY 3 study demonstrated that a combination of half-dose diuretics can significantly reduce blood pressure without the adverse effects associated with full doses of either diuretic alone, as reported at the European Society of Cardiology Congress 2015.

Newer Genetic Testing Technologies May Help Autism Dx in Children

Newer genetic tests like chromosomal microarray analysis and whole-exome sequencing for children with autism spectrum disorder (ASD) may help detect genetic mutations potentially associated to the disorder, a study published in JAMA reported.

Calorie Restriction May Modify Risk Factors for Age-Related Diseases

According to a new study, calorie restriction may modify risk factors for age-related diseases and indicators associated with longer life span.

'Heart Age' Greater Than Actual Age for Most Adults

A new report from the Centers for Disease Control and Prevention (CDC) found that one in two men and two in five women have a heart age five or more years older than their actual age based on risk factors.

Less Sleep May Up Risk of Catching a Cold

A new study emphasizes the important of a good night's sleep, as sleeping six or fewer hours or per night more than quadrupled the risk of developing a cold in healthy patients in a study published in the journal Sleep.

Are Preoperative Statins in Non-Cardiac Surgery Beneficial?

Preoperative statins reduced cardiac complications and mortality in patients who underwent non-cardiac surgery, according to a new study presented at the European Society of Cardiology Congress 2015.

Bleeding, Stroke Rates With Rivaroxaban in AF Patients Presented at ESC

Oral anticoagulation with rivaroxaban for stroke prevention in atrial fibrillation (AF) patients resulted in low rates of bleeding and stroke, researchers presented at the European Society of Cardiology Congress 2015.

Bivalirudin Assessed for Major Cardiovascular Events in ACS

For patients with an acute coronary syndrome undergoing percutaneous coronary intervention (PCI), bivalirudin does not lower the rates of major adverse cardiovascular events.

Benznidazole Tx Explored in Chagas' Cardiomyopathy

For patients with established Chagas' cardiomyopathy, benznidazole may reduce serum parasite detection.